Autumn Glory Partners’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$730K Buy
30,127
+2,530
+9% +$61.2K 0.21% 110
2026
Q1
$669K Buy
27,597
+30
+0.1% +$728 0.25% 97
2025
Q4
$669K Buy
27,567
+63
+0.2% +$1.53K 0.23% 107
2025
Q3
$669K Buy
27,504
+954
+4% +$23.1K 0.27% 96
2025
Q2
$644K Sell
26,550
-260
-1% -$6.27K 0.3% 88
2025
Q1
$648K Buy
26,810
+2,000
+8% +$48.1K 0.32% 91
2024
Q4
$594K Sell
24,810
-1,580
-6% -$38K 0.29% 89
2024
Q3
$643K Sell
26,390
-426
-2% -$10.3K 0.25% 104
2024
Q2
$636K Buy
26,816
+4,460
+20% +$105K 0.32% 82
2024
Q1
$532K Hold
22,356
0.26% 87
2023
Q4
$535K Buy
22,356
+712
+3% +$16.6K 0.31% 85
2023
Q3
$501K Buy
21,644
+6,414
+42% +$150K 0.31% 83
2023
Q2
$358K Buy
+15,230
New +$360K 0.26% 89

Other funds holding IBDS

Autumn Glory Partners's IBDS Position: Q2 2026 in Review

Autumn Glory Partners increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 9.2% in Q2 2026, buying an estimated $61.2K and bringing the position to 30,127 shares worth $730K. The position accounts for 0.21% of the portfolio, ranked #110.

Autumn Glory Partners first reported a position in IBDS in Q2 2023 and has held it in 13 quarters since. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Autumn Glory Partners held 30,127 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $730K as of Q2 2026.
  • Autumn Glory Partners bought 2,530 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $61.2K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.21% of Autumn Glory Partners's portfolio in Q2 2026, its #110 holding.
  • Autumn Glory Partners first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2023 and has held it in 13 quarters since.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Autumn Glory Partners's 13F filing for Q2 2026, filed 3 Aug 2026.